Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

ATEF S TAWFIK

Allopathic & Osteopathic Physicians Family Medicine

NPI
1629007067
CMS profile
722919
Location
LOS ANGELES, CA

General Payments · PY2018

$667.84

  • Reported across 41 records
  • CMS publication 2026-01-23

Latest program year · PY2018

$667.84

41 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2018 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $667.84 41

By paying entity

PY2018 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $667.84 41

Payment records · PY2018 (41)

Sorted by paying entity, then date · as published by CMS

Program year 2018
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Astellas Pharma US Inc $22.01 01/05/2018 Food and Beverage Undisputed 01/23/2026 582521063 CMS
AstraZeneca Pharmaceuticals LP $18.61 05/07/2018 Food and Beverage Undisputed 01/23/2026 560104959 CMS
Gilead Sciences, Inc. $17.43 09/17/2018 Food and Beverage Undisputed 01/23/2026 592595949 CMS
GlaxoSmithKline, LLC. $16.95 02/05/2018 Food and Beverage Undisputed 01/23/2026 593930209 CMS
GlaxoSmithKline, LLC. $14.32 03/01/2018 Food and Beverage Undisputed 01/23/2026 594011579 CMS
GlaxoSmithKline, LLC. $16.46 04/24/2018 Food and Beverage Undisputed 01/23/2026 594241121 CMS
GlaxoSmithKline, LLC. $16.46 07/30/2018 Food and Beverage Undisputed 01/23/2026 595705661 CMS
GlaxoSmithKline, LLC. $21.18 09/18/2018 Food and Beverage Undisputed 01/23/2026 596038463 CMS
GlaxoSmithKline, LLC. $22.33 12/17/2018 Food and Beverage Undisputed 01/23/2026 596763981 CMS
Lilly USA, LLC $24.09 01/29/2018 Food and Beverage Undisputed 01/23/2026 559201309 CMS
Lilly USA, LLC $2.13 02/26/2018 Food and Beverage Undisputed 01/23/2026 559201293 CMS
Lilly USA, LLC $9.14 02/27/2018 Food and Beverage Undisputed 01/23/2026 559201295 CMS
Lilly USA, LLC $14.07 04/03/2018 Food and Beverage Undisputed 01/23/2026 559201299 CMS
Lilly USA, LLC $5.11 04/09/2018 Food and Beverage Undisputed 01/23/2026 559201311 CMS
Lilly USA, LLC $18.15 05/08/2018 Food and Beverage Undisputed 01/23/2026 559201303 CMS
Lilly USA, LLC $14.30 07/31/2018 Food and Beverage Undisputed 01/23/2026 559201315 CMS
Lilly USA, LLC $18.64 10/02/2018 Food and Beverage Undisputed 01/23/2026 559201306 CMS
Lilly USA, LLC $13.05 12/12/2018 Food and Beverage Undisputed 01/23/2026 559201319 CMS
Merck Sharp & Dohme Corporation $15.73 01/16/2018 Food and Beverage Undisputed 01/23/2026 604191915 CMS
Merck Sharp & Dohme Corporation $18.00 03/06/2018 Food and Beverage Undisputed 01/23/2026 604295537 CMS
Merck Sharp & Dohme Corporation $18.69 04/17/2018 Food and Beverage Undisputed 01/23/2026 604333041 CMS
Merck Sharp & Dohme Corporation $18.63 06/18/2018 Food and Beverage Undisputed 01/23/2026 604479065 CMS
Merck Sharp & Dohme Corporation $11.05 09/20/2018 Food and Beverage Undisputed 01/23/2026 604634601 CMS
Novartis Pharmaceuticals Corporation $14.20 01/09/2018 Food and Beverage Undisputed 01/23/2026 608754075 CMS
Novartis Pharmaceuticals Corporation $13.29 02/20/2018 Food and Beverage Undisputed 01/23/2026 608754077 CMS
Novartis Pharmaceuticals Corporation $12.61 04/02/2018 Food and Beverage Undisputed 01/23/2026 608754081 CMS
Novartis Pharmaceuticals Corporation $12.34 08/21/2018 Food and Beverage Undisputed 01/23/2026 608754079 CMS
Novartis Pharmaceuticals Corporation $17.64 12/18/2018 Food and Beverage Undisputed 01/23/2026 608754073 CMS
Novo Nordisk Inc $22.85 02/25/2018 Food and Beverage Undisputed 01/23/2026 588856551 CMS
Novo Nordisk Inc $18.40 04/30/2018 Food and Beverage Undisputed 01/23/2026 588856563 CMS
Novo Nordisk Inc $13.53 05/22/2018 Food and Beverage Undisputed 01/23/2026 588856567 CMS
Novo Nordisk Inc $16.21 08/21/2018 Food and Beverage Undisputed 01/23/2026 588856559 CMS
PFIZER INC. $15.80 02/03/2018 Food and Beverage Undisputed 01/23/2026 610725005 CMS
Phadia US Inc. $18.94 04/30/2018 Food and Beverage Undisputed 01/23/2026 590552331 CMS
Takeda Pharmaceuticals U.S.A., Inc. $20.22 04/03/2018 Food and Beverage Undisputed 01/23/2026 590100893 CMS
Takeda Pharmaceuticals U.S.A., Inc. $5.63 05/08/2018 Food and Beverage Undisputed 01/23/2026 589419085 CMS
Takeda Pharmaceuticals U.S.A., Inc. $17.94 05/15/2018 Food and Beverage Undisputed 01/23/2026 589311479 CMS
Takeda Pharmaceuticals U.S.A., Inc. $22.23 06/11/2018 Food and Beverage Undisputed 01/23/2026 589270966 CMS
Takeda Pharmaceuticals U.S.A., Inc. $18.01 09/25/2018 Food and Beverage Undisputed 01/23/2026 590068523 CMS
Teva Pharmaceuticals USA, Inc. $22.30 10/16/2018 Food and Beverage Undisputed 01/23/2026 614016513 CMS
Teva Pharmaceuticals USA, Inc. $19.17 11/21/2018 Food and Beverage Undisputed 01/23/2026 613955881 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018
Source files
Dataset page · Bulk file · PY2018
Generated from
OP_DTL_GNRL_PGYR2018_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.